Clinical Trials Directory

Trials / Conditions / Stage IV Esophageal Cancer

Stage IV Esophageal Cancer

19 registered clinical trials studyying Stage IV Esophageal Cancer.

StatusTrialSponsorPhase
UnknownA Study of Creatine Combined With Curcumin in the Intervention of Early Cachexia in Upper Gastrointestinal Tum
NCT05856500
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolN/A
UnknownImproving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced Cancer
NCT04670445
Massachusetts General HospitalN/A
CompletedHealth Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer
NCT03154190
Stanford UniversityN/A
WithdrawnC-Met Inhibitor AMG 337, Oxaliplatin, Leucovorin Calcium, and Fluorouracil in Treating Patients With Advanced
NCT02344810
Eastern Cooperative Oncology GroupPhase 1 / Phase 2
TerminatedPaclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection
NCT01249443
AIDS Malignancy ConsortiumPhase 1
CompletedPilot Trial of CRLX101 in Treatment of Patients With Advanced or Metastatic Stomach, Gastroesophageal, or Esop
NCT01612546
City of Hope Medical CenterPhase 2
TerminatedAkt Inhibitor MK2206, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With Locally Advanced or Meta
NCT01705340
National Cancer Institute (NCI)Phase 1
CompletedVaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors
NCT01522820
Roswell Park Cancer InstitutePhase 1
CompletedEverolimus and Combination Chemotherapy in Treating Patients With Metastatic Stomach or Esophageal Cancer
NCT01231399
City of Hope Medical CenterPhase 1 / Phase 2
CompletedPralatrexate and Docetaxel in Treating Patients With Stage IV Esophageal or Gastroesophageal Cancer Who Have F
NCT01129206
Ohio State University Comprehensive Cancer CenterPhase 2
CompletedSaracatinib in Treating Patients With Locally Advanced or Metastatic Stomach or Gastroesophageal Junction Canc
NCT00607594
National Cancer Institute (NCI)Phase 2
CompletedErlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Nec
NCT00397384
National Cancer Institute (NCI)Phase 1
Completed3-AP Plus Cisplatin in Treating Patients With Recurrent or Metastatic Adenocarcinoma of the Esophagus or Gastr
NCT00077545
National Cancer Institute (NCI)Phase 2
TerminatedArsenic Trioxide in Treating Patients With Advanced Cancer of the Esophagus or Gastroesophageal Junction
NCT00061958
National Cancer Institute (NCI)Phase 2
TerminatedA Phase I/II Study of Oblimersen Plus Cisplatin and Fluorouracil in Gastric & Esophageal Junction Cancer
NCT00064259
National Cancer Institute (NCI)Phase 1 / Phase 2
CompletedErlotinib Hydrochloride in Treating Patients With Advanced Esophageal Cancer or Stomach Cancer
NCT00045526
National Cancer Institute (NCI)Phase 2
CompletedErlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction
NCT00030498
National Cancer Institute (NCI)Phase 1
Completed7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid
NCT00031681
National Cancer Institute (NCI)Phase 1
CompletedInterleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu
NCT00004074
National Cancer Institute (NCI)Phase 1